CONMED CORP's ticker is and the CUSIP is 207410AF8. A total of 38 filers reported holding CONMED CORP in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,153 | -25.0% | 1,000 | 0.0% | 0.00% | – |
| Q2 2023 | $1,538 | -75.0% | 1,000 | -80.0% | 0.00% | – |
| Q1 2023 | $6,143 | +8.4% | 5,000 | 0.0% | 0.00% | – |
| Q4 2022 | $5,665 | -29.2% | 5,000 | -28.6% | 0.00% | – |
| Q3 2022 | $8,000 | 0.0% | 7,000 | 0.0% | 0.00% | – |
| Q2 2022 | $8,000 | -33.3% | 7,000 | 0.0% | 0.00% | – |
| Q1 2022 | $12,000 | 0.0% | 7,000 | 0.0% | 0.00% | – |
| Q4 2021 | $12,000 | +9.1% | 7,000 | 0.0% | 0.00% | – |
| Q3 2021 | $11,000 | -99.3% | 7,000 | -99.3% | 0.00% | -100.0% |
| Q2 2021 | $1,611,000 | +46.2% | 1,000,000 | +41.8% | 0.00% | 0.0% |
| Q1 2021 | $1,102,000 | -27.4% | 705,000 | -35.0% | 0.00% | 0.0% |
| Q4 2020 | $1,517,000 | +34.1% | 1,085,000 | +7.4% | 0.00% | 0.0% |
| Q3 2020 | $1,131,000 | -49.8% | 1,010,000 | -53.1% | 0.00% | -50.0% |
| Q2 2020 | $2,253,000 | – | 2,153,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opti Capital Management, LP | 44,065,000 | $71,296,000 | 7.64% |
| Mohican Financial Management, LLC | 3,000,000 | $4,878,000 | 1.90% |
| SHENKMAN CAPITAL MANAGEMENT INC | 9,398,000 | $15,357,000 | 1.40% |
| OSTERWEIS CAPITAL MANAGEMENT INC | 8,930,000 | $14,433,000 | 0.74% |
| SSI INVESTMENT MANAGEMENT LLC | 6,454,000 | $10,396,000 | 0.67% |
| MACKAY SHIELDS LLC | 38,286,000 | $61,845,000 | 0.58% |
| PALISADE CAPITAL MANAGEMENT, LP | 5,208,000 | $8,417,000 | 0.19% |
| Calamos Advisors LLC | 23,085,000 | $37,345,000 | 0.17% |
| Polar Asset Management Partners Inc. | 10,000,000 | $16,168,000 | 0.17% |
| Calamos Wealth Management LLC | 1,026,000 | $1,660,000 | 0.13% |